Bristol Myers Squibb, Tubulis ink pact for development of next generation ADCs for cancer patients treatment Ruchika Sharma23 April 2023 11:00 AM ISTThe terms of the agreement include an upfront payment of USD 22.75 million to Tubulis in addition to the potential for over USD 1 billion in...
Bristol Myers Squibb gets positive EMA Committee opinion for Breyanzi for Relapsed or Refractory Large B-cell Lymphoma after one prior therapy Ruchika Sharma2 April 2023 10:00 AM ISTBreyanzi is a CD19-directed CAR T cell therapy with a 4-1BB costimulatory domain, which enhances the expansion and persistence of the CAR T cells.
Bristol Myers Squibb Sotyktu gets European Commission nod for adults with plaque psoriasis Ruchika Sharma30 March 2023 1:24 PM ISTSotyktu is an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor with a unique mechanism of action, representing a new class of small...
Pfizer, Bristol Myers, AbbVie drugs likely to face US price negotiation Ruchika Sharma14 March 2023 3:30 PM ISTNovo Nordisk's diabetes drug Ozempic, prostate cancer treatment Xtandi from Astellas Pharma and Pfizer, and J&J's blood thinner Xarelto are on three...
Natco Pharma rolls out additional strengths for generic version of Revlimid in US Ruchika Sharma10 March 2023 2:15 PM ISTLenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
Cancer drug: Aurobindo Pharma arm Eugia Pharma gets USFDA approval for Lenalidomide Capsules Ruchika Sharma9 March 2023 1:15 PM ISTThe approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone.
Bristol Myers Squibb, Janssen launch Phase 3 Librexia clinical trial program evaluating Milvexian Ruchika Sharma5 March 2023 2:30 PM ISTPrinceton: Bristol Myers Squibb in collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson...
Bristol Myers Squibb Reblozyl gets European Commission nod for anemia due to Beta Thalassemia Ruchika Sharma5 March 2023 11:30 AM ISTReblozyl, a first-in-class therapeutic option, promotes late-stage red blood cell maturation in animal models.
USFDA accepts Bristol Myers Squibb sBLA for Opdivo for Resected Stage IIB/C Melanoma Ruchika Sharma4 March 2023 10:00 AM ISTMelanoma is a form of skin cancer characterized by the uncontrolled growth of pigment-producing cells (melanocytes) located in the skin.
Bristol Myers Squibb wins dismissal of USD 6.4 billion lawsuit over cancer drug delay Ruchika Sharma3 March 2023 2:30 PM ISTNew York: A U.S. judge on Wednesday dismissed a lawsuit accusing Bristol Myers Squibb Co of defrauding investors who stood to receive $6.4 billion had...
Bristol Myers Squibb to establish state of -the-art site in Hyderabad with investment of Rs 800 crore Ruchika Sharma23 Feb 2023 4:30 PM ISTSamit Hirawat said the new BMS site in Hyderabad will also create significant employment and economic opportunities locally as we continue to grow our...
Bristol Myers Squibb concludes sale of New York manufacturing facility Ruchika Sharma4 Jan 2023 2:30 PM ISTNew York: Bristol Myers Squibb has completed the previously announced sale of its manufacturing facility in Syracuse, New York to LOTTE...
